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characteristic of infection (Figure). Spatial information is
retained allowing for visualization and quantiﬁcation of
disease within individual lobes. The relative volumes for
each classiﬁcation are determined by normalizing the sum
of all voxels within a particular class to the total lung
volume. Using HRCT, broncho-alveolar lavage (BAL) and
spirometry data, 55 SCT recipients were classiﬁed into one
of 3 groups: A) Infection, no BOS (n¼11); B) BOS, no
infection (n¼34); and C) BOS + Infection (n¼9). BAL were
performed within 1 week of the HRCT, in all 55 patients.
Mean values (SE) for functional small airway disease
(fSAD), parenchymal (infectious) disease (PD), and normal
lung parenchyma were determined for each group
(Figure).
Results: Distinct imaging proﬁles were identiﬁed for pa-
tients with BOS and for patients with an acute infectious
pneumonitis. In particular, the %fSAD was signiﬁcantly
greater in patients with BOS when compared to those with
infection alone, 382% vs 174%, p¼0.05. There was no
difference in the %fSAD for subjects with BOS, whether a
concurrent infection was present or not, 353% (BOS) vs
382% (BOS + Infection), p¼31. Patients with an acute in-
fectious pneumonitis had signiﬁcantly higher levels of PD
than patients with BOS, 304% vs 171.5%. In 7 of the 34
(21%) BOS cases, signiﬁcant increases in fSAD (>30%) were
present when radiographic features characteristic for BOS
(air trapping, bronchiectasis, septal lines) were either ab-
sent or minimal on HRCT. There were no differences in
PRM imaging by the type of infection. PRM provides a
major advance in our ability to diagnose small airway
obstruction that characterizes BOS, even in the presence of
an active pulmonary infection. A prospective trial
comparing PRM with spirometry and standard HRCT as an
early indicator of BOS is planned.CRA -DATA MANAGEMENT313
Transplant Center Survey of CIBMTR Internal Assessments
Nicolette Maria Minas, Kathleen Ruehle. Greenebaum Cancer
Center, University of Maryland, Baltimore, MD
Background: The University of Maryland Blood and Marrow
Transplant (BMT) team has ﬁrmly established a culture of
continuous quality improvement to assure the utmost ac-
curacy of CIBMTR data. In early 2012, Minas and Ruehlereported the signiﬁcance of auditing 10 commonly used
data points. In early 2013, Minas and Ruehle set out to
further improve CIBMTR data accuracy by combining their
original set of commonly used data points with 19 addi-
tional ones.
Methods: To explore the internal assessments (IA) audit
activities used by other transplant centers to ensure
CIBMTR data accuracy, the University of Maryland BMT
team developed an anonymous survey consisting of 6
quantitative and 3 qualitative questions. One hundred and
thirty seven NMDP (National Marrow Donor Program) and
CIBMTR (Center for International Blood and Marrow
Transplant Research) afﬁliated transplant centers (TC) were
invited to participate. The survey was administered using
Survey Monkey.
Results: A total of 86 (62.8%) responses were received. Of
these, 57% were from centers that transplanted over 100
patients per year. Most TC (89%) performed some type of IA
for their CIBMTR forms. Centers reported that IA were most
often conducted by a quality assurancemanager (46%). Of the
TC that performed IA, 76% reported using FACT (Foundation
for the Accreditation of Cellular Therapy) and additional data
points as opposed to only FACT data points. Fifty-six percent
of TC that conducted IA reported that audits were performed
on 10%-30% of patient data on a regular basis, while another
19% reported performing IA for 100% of patient data. Internal
assessments were most commonly performed on a quarterly
basis (35%).
Conclusion: Most TC participate in some sort of IA. The
majority of TC perform IA using FACT and additional data
points, which likely improves accuracy of the data. Although
time is a consideration, completing 100% IA assures the most
accurate data. Surveys such as these provide us with
knowledge of how all transplant centers assure quality
CIBMTR data and prepare for external audits, such as CIBMTR
and FACT.
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Organizing data into coherent groups, i.e. data domains, is
key to understanding relations between complex subject
areas such as information collected around one simple
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by the number of transplants that are part of the CIBMTR
Outcomes Research Database underlines the need for
structures that document this ’data about data’ (Metadata).
The difﬁculty is showing how the complete set of data
around a transplant event is connected in a way that
transcends the collection method, i.e. form. Our aim was to
demonstrate that a domain-driven architecture aligns with
the forms-based model, and eases the introduction of
collecting more data about HCT transplant events. The
Biomedical Research Integrated Domain Group (BRIDG)
model is publically available. The goal of BRIDG group is to
have a common view of the data exchanged for semantic
interoperability. The BRIDG model is intended to balance
the concerns of the larger health care community, while
being speciﬁc enough to apply to a particular subject area
such as HCT. We extracted all Common Data Elements
(CDEs) for all CIBMTR-mandated forms and associated each
element to one of three contexts, Recipient, Donor and
stem-cell product; most elements were in the Recipient
context. Because no element could be described in isola-
tion, instance diagrams were created to describe how one
simple concept needed multiple BRIDG entities to be fully
described. Some CDEs were described as relationships
between entities rather than an attribute of an entity. We
extended the generic BRIDG model to contain all identiﬁed
elements. To this end, we requested the expansion of the
BRIDG model to include a ’PerformedSubstanceExtraction’
entity at the same level of inheritance as ’Perform-
edSubstanceAdministration’. While the collection of a
stem-cell product could have been described in the context
of a ’Product’ and a ’SpecimenCollection’, the richness of
the relationship between a Donor and a Recipient would
not have been as obvious. This as well as other enhance-
ments to the BRIDG model were included in BRIDG version
3.2. With this effort, we have documented each data point
(CDE) collected on all the CIBMTR-mandated forms and the
relationships between them. We intend to use the UML
BRIDG model with the added HCT content as the speciﬁ-
cation for a physical database model. This physical model
will help remove barriers that transplant centers experi-
ence in electronic transfer of HCT data to the Stem Cell
Transplant Outcomes Database by providing a foundation
upon which to develop their own in-house data systems,
and eventual development of Electronic Medical Record
(EMR) integration engines to submit data to the Outcomes
Database.315
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Background: Interpersonal communication is an intangible
- and often overlooked - barrier to data management and
error reduction. Reporting to the Center for International
Blood and Marrow Transplant Research (CIBMTR) and in-
ternal databases requires comprehensive data manage-
ment techniques e including communication processes.
Facilitation of interpersonal communication among clinical
teams has become increasingly important in healthcare
due to potentially adverse outcomes of a communicationfailure (see Leonard, Graham, & Bonacum, 2004; Marshal,
Harrison, & Flanagan, 2009; Propp et. al, 2010) Sutcliffe,
Lewton, & Rosenthal, 2004). A poor BMT Physician-
research coordinator relationship may result in closed
communication, a lack of transparency throughout the
clinical team, and insufﬁcient data collection and reporting
to CIBMTR. Thus, we recommend actions targeted at
removing barriers to reciprocal physician-coordinator
communication.
Methods targeting improved communication: (a.) Physi-
cian Sign-off: physician-reviewed data veriﬁcation encour-
ages open discussion and review of essential CIBMTR data
prior to transplant; (b.) Rounding: opportunities to attend in-
patient rounds with the entire clinical team increases coor-
dinator knowledge base and permits a transparent view of
the continuum of care. (c.) Research Nurse Relationships:
highly-accessible and responsive nurses serve as key liaisons
between coordinators and the clinical team; (d.) Disease
In-service & Education: small group continuing education
sessions allow teaching moments between physicians and
coordinators; (e.) Direct and Real-Time communication:
reducing hierarchical barriers allows any team member to
directly contact/speak to a physician or use electronic
communication to share patient status updates (e.g., re-
lapses, deaths); (f.) Team Engagement Events: social events
encourage networking and relationship development (e.g.,
NMDP Be the Match - Toss the boss, Leukemia & Lymphoma
Society, and after work events).
Future: Interpersonal communication is essential to our
good clinical practices and embedded in our standard
operating procedures. Removing communication barriers
and improving relationships has been a critical success
factor for our team. Our objective is to continue identifying
communication failures while maintaining reciprocal re-
lationships e particularly during times of turnover and
transition.316
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Background: AE capture and reporting is one of the most
time-consuming activities related to the conduct of he-
matopoietic stem cell transplant (HSCT) clinical trials, with
some trials requiring hundreds of AEs to be captured and
summarized for reporting. To improve the AE reporting
process, our HSCT Program collaborated with the Univer-
sity of Virginia Biomedical Informatics Division of the
Public Health Sciences Department to develop a novel
electronic data capture tool. The purpose of this study was
to evaluate the tool’s efﬁciency and identify areas for
improvement.
Methods: The electronic tool was designed to be quick,
simple to use, and easy to deploy. Microsoft Excel array for-
mulas were used, allowing a calculation to be carried out
